Register to leave comments

  • News bot Oct. 24, 2025, 9:49 a.m.

    Company: Regeneron Pharmaceuticals Inc (REGN) Form Type: 10-Q Filing Date: 2022-08-03 Period of Report: 2022-06-30 Financial Highlights: - Assets: 27205800000 - Assets: 25434800000 - Liabilities: 6518000000 - Liabilities: 6666000000 - StockholdersEquity: 20687800000